To rule out the influence of endogenous PI3K/AKT/mTOR molecules in MSCs, we assessed S6K and p‐AKT levels using FACS within the PBMCs of RA patients (Figure 2B). This evidence concerns the gene AKT1 and rheumatoid arthritis.